Trials / Completed
CompletedNCT04836325
Effect of Transcranial Static Magnetic Field Stimulation in Fibromyalgia Syndrome
Effect of Transcranial Static Magnetic Field Stimulation Over the Primary Motor Cortex in Fibromyalgia Syndrome: A Randomized Controlled Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- University of Seville · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The main objective is to know if the transcranial static magnetic field stimulation (tSMS) reduces the perception of pain in patients with fibromyalgia and its effect on health-related quality of life. In addition, it will seek to limit the parameters necessary to achieve efficiency with the technique.
Detailed description
Background: Various non-invasive brain stimulation techniques have been successfully tested in fibromyalgia syndrome (FMS). Transcranial static magnetic field stimulation (tSMS) is a new, portable and inexpensive non invasive brain stimulation (NIBS) technique that has shown security, biological effects, and therapeutical effects in some pathologies. Some studies have studied its effect in pain central processing, our aim is to study its effect on FMS. The safety that tSMS has demonstrated in several clinical trials opens doors to future clinical trials that will extend its clinical utility. Objectives: To investigate the effect of tSMS on pain in patients with FMS, using subjective and objective assessment measures. Identify dose response to the treatment to limit the parameters required to achieve effectiveness with the technique.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | transcranial static magnetic field stimulation (tSMS) | The intervention group will receive a treatment of tSMS in the primary motor cortex. |
| PROCEDURE | Sham transcranial static magnetic field stimulation | The placebo group will receive a dummy treatment |
Timeline
- Start date
- 2021-04-19
- Primary completion
- 2021-10-31
- Completion
- 2021-11-30
- First posted
- 2021-04-08
- Last updated
- 2022-06-08
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04836325. Inclusion in this directory is not an endorsement.